[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Radiation Curable Formulation Market Growth 2023-2029

March 2023 | 116 pages | ID: GD83D39F216CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Radiation Curable Formulation Industry Forecast” looks at past sales and reviews total world Radiation Curable Formulation sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiation Curable Formulation sales for 2023 through 2029. With Radiation Curable Formulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiation Curable Formulation industry.

This Insight Report provides a comprehensive analysis of the global Radiation Curable Formulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiation Curable Formulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radiation Curable Formulation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiation Curable Formulation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiation Curable Formulation.

The global Radiation Curable Formulation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Radiation Curable Formulation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Radiation Curable Formulation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Radiation Curable Formulation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Radiation Curable Formulation players cover BASF SE, DIC, Arkema (Sartomer), Cytec (Solvay S.A.), DuPont, Royal DSM, IGM Resins, Allnex and Chongqing Changfeng Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiation Curable Formulation market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Ultraviolet (UV) Curing
  • Electron beam (EB) Curing
Segmentation by application
  • Coatings
  • Inks
  • Adhesives
  • Electronics
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • BASF SE
  • DIC
  • Arkema (Sartomer)
  • Cytec (Solvay S.A.)
  • DuPont
  • Royal DSM
  • IGM Resins
  • Allnex
  • Chongqing Changfeng Chemical
  • Eternal Materials
  • Miwon Specialty Chemical
  • Jiangsu Sanmu Group
  • PPG
  • T&K TOKA
  • Heygey
  • Suzhou Mingda
  • Himonia
  • Tianjin Jiuri New
Key Questions Addressed in this Report

What is the 10-year outlook for the global Radiation Curable Formulation market?

What factors are driving Radiation Curable Formulation market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Radiation Curable Formulation market opportunities vary by end market size?

How does Radiation Curable Formulation break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Radiation Curable Formulation Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Radiation Curable Formulation by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Radiation Curable Formulation by Country/Region, 2018, 2022 & 2029
2.2 Radiation Curable Formulation Segment by Type
  2.2.1 Ultraviolet (UV) Curing
  2.2.2 Electron beam (EB) Curing
2.3 Radiation Curable Formulation Sales by Type
  2.3.1 Global Radiation Curable Formulation Sales Market Share by Type (2018-2023)
  2.3.2 Global Radiation Curable Formulation Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Radiation Curable Formulation Sale Price by Type (2018-2023)
2.4 Radiation Curable Formulation Segment by Application
  2.4.1 Coatings
  2.4.2 Inks
  2.4.3 Adhesives
  2.4.4 Electronics
2.5 Radiation Curable Formulation Sales by Application
  2.5.1 Global Radiation Curable Formulation Sale Market Share by Application (2018-2023)
  2.5.2 Global Radiation Curable Formulation Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Radiation Curable Formulation Sale Price by Application (2018-2023)

3 GLOBAL RADIATION CURABLE FORMULATION BY COMPANY

3.1 Global Radiation Curable Formulation Breakdown Data by Company
  3.1.1 Global Radiation Curable Formulation Annual Sales by Company (2018-2023)
  3.1.2 Global Radiation Curable Formulation Sales Market Share by Company (2018-2023)
3.2 Global Radiation Curable Formulation Annual Revenue by Company (2018-2023)
  3.2.1 Global Radiation Curable Formulation Revenue by Company (2018-2023)
  3.2.2 Global Radiation Curable Formulation Revenue Market Share by Company (2018-2023)
3.3 Global Radiation Curable Formulation Sale Price by Company
3.4 Key Manufacturers Radiation Curable Formulation Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Radiation Curable Formulation Product Location Distribution
  3.4.2 Players Radiation Curable Formulation Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR RADIATION CURABLE FORMULATION BY GEOGRAPHIC REGION

4.1 World Historic Radiation Curable Formulation Market Size by Geographic Region (2018-2023)
  4.1.1 Global Radiation Curable Formulation Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Radiation Curable Formulation Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Radiation Curable Formulation Market Size by Country/Region (2018-2023)
  4.2.1 Global Radiation Curable Formulation Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Radiation Curable Formulation Annual Revenue by Country/Region (2018-2023)
4.3 Americas Radiation Curable Formulation Sales Growth
4.4 APAC Radiation Curable Formulation Sales Growth
4.5 Europe Radiation Curable Formulation Sales Growth
4.6 Middle East & Africa Radiation Curable Formulation Sales Growth

5 AMERICAS

5.1 Americas Radiation Curable Formulation Sales by Country
  5.1.1 Americas Radiation Curable Formulation Sales by Country (2018-2023)
  5.1.2 Americas Radiation Curable Formulation Revenue by Country (2018-2023)
5.2 Americas Radiation Curable Formulation Sales by Type
5.3 Americas Radiation Curable Formulation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Radiation Curable Formulation Sales by Region
  6.1.1 APAC Radiation Curable Formulation Sales by Region (2018-2023)
  6.1.2 APAC Radiation Curable Formulation Revenue by Region (2018-2023)
6.2 APAC Radiation Curable Formulation Sales by Type
6.3 APAC Radiation Curable Formulation Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Radiation Curable Formulation by Country
  7.1.1 Europe Radiation Curable Formulation Sales by Country (2018-2023)
  7.1.2 Europe Radiation Curable Formulation Revenue by Country (2018-2023)
7.2 Europe Radiation Curable Formulation Sales by Type
7.3 Europe Radiation Curable Formulation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Radiation Curable Formulation by Country
  8.1.1 Middle East & Africa Radiation Curable Formulation Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Radiation Curable Formulation Revenue by Country (2018-2023)
8.2 Middle East & Africa Radiation Curable Formulation Sales by Type
8.3 Middle East & Africa Radiation Curable Formulation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiation Curable Formulation
10.3 Manufacturing Process Analysis of Radiation Curable Formulation
10.4 Industry Chain Structure of Radiation Curable Formulation

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Radiation Curable Formulation Distributors
11.3 Radiation Curable Formulation Customer

12 WORLD FORECAST REVIEW FOR RADIATION CURABLE FORMULATION BY GEOGRAPHIC REGION

12.1 Global Radiation Curable Formulation Market Size Forecast by Region
  12.1.1 Global Radiation Curable Formulation Forecast by Region (2024-2029)
  12.1.2 Global Radiation Curable Formulation Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiation Curable Formulation Forecast by Type
12.7 Global Radiation Curable Formulation Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 BASF SE
  13.1.1 BASF SE Company Information
  13.1.2 BASF SE Radiation Curable Formulation Product Portfolios and Specifications
  13.1.3 BASF SE Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 BASF SE Main Business Overview
  13.1.5 BASF SE Latest Developments
13.2 DIC
  13.2.1 DIC Company Information
  13.2.2 DIC Radiation Curable Formulation Product Portfolios and Specifications
  13.2.3 DIC Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 DIC Main Business Overview
  13.2.5 DIC Latest Developments
13.3 Arkema (Sartomer)
  13.3.1 Arkema (Sartomer) Company Information
  13.3.2 Arkema (Sartomer) Radiation Curable Formulation Product Portfolios and Specifications
  13.3.3 Arkema (Sartomer) Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Arkema (Sartomer) Main Business Overview
  13.3.5 Arkema (Sartomer) Latest Developments
13.4 Cytec (Solvay S.A.)
  13.4.1 Cytec (Solvay S.A.) Company Information
  13.4.2 Cytec (Solvay S.A.) Radiation Curable Formulation Product Portfolios and Specifications
  13.4.3 Cytec (Solvay S.A.) Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Cytec (Solvay S.A.) Main Business Overview
  13.4.5 Cytec (Solvay S.A.) Latest Developments
13.5 DuPont
  13.5.1 DuPont Company Information
  13.5.2 DuPont Radiation Curable Formulation Product Portfolios and Specifications
  13.5.3 DuPont Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 DuPont Main Business Overview
  13.5.5 DuPont Latest Developments
13.6 Royal DSM
  13.6.1 Royal DSM Company Information
  13.6.2 Royal DSM Radiation Curable Formulation Product Portfolios and Specifications
  13.6.3 Royal DSM Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Royal DSM Main Business Overview
  13.6.5 Royal DSM Latest Developments
13.7 IGM Resins
  13.7.1 IGM Resins Company Information
  13.7.2 IGM Resins Radiation Curable Formulation Product Portfolios and Specifications
  13.7.3 IGM Resins Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 IGM Resins Main Business Overview
  13.7.5 IGM Resins Latest Developments
13.8 Allnex
  13.8.1 Allnex Company Information
  13.8.2 Allnex Radiation Curable Formulation Product Portfolios and Specifications
  13.8.3 Allnex Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Allnex Main Business Overview
  13.8.5 Allnex Latest Developments
13.9 Chongqing Changfeng Chemical
  13.9.1 Chongqing Changfeng Chemical Company Information
  13.9.2 Chongqing Changfeng Chemical Radiation Curable Formulation Product Portfolios and Specifications
  13.9.3 Chongqing Changfeng Chemical Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Chongqing Changfeng Chemical Main Business Overview
  13.9.5 Chongqing Changfeng Chemical Latest Developments
13.10 Eternal Materials
  13.10.1 Eternal Materials Company Information
  13.10.2 Eternal Materials Radiation Curable Formulation Product Portfolios and Specifications
  13.10.3 Eternal Materials Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Eternal Materials Main Business Overview
  13.10.5 Eternal Materials Latest Developments
13.11 Miwon Specialty Chemical
  13.11.1 Miwon Specialty Chemical Company Information
  13.11.2 Miwon Specialty Chemical Radiation Curable Formulation Product Portfolios and Specifications
  13.11.3 Miwon Specialty Chemical Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Miwon Specialty Chemical Main Business Overview
  13.11.5 Miwon Specialty Chemical Latest Developments
13.12 Jiangsu Sanmu Group
  13.12.1 Jiangsu Sanmu Group Company Information
  13.12.2 Jiangsu Sanmu Group Radiation Curable Formulation Product Portfolios and Specifications
  13.12.3 Jiangsu Sanmu Group Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Jiangsu Sanmu Group Main Business Overview
  13.12.5 Jiangsu Sanmu Group Latest Developments
13.13 PPG
  13.13.1 PPG Company Information
  13.13.2 PPG Radiation Curable Formulation Product Portfolios and Specifications
  13.13.3 PPG Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 PPG Main Business Overview
  13.13.5 PPG Latest Developments
13.14 T&K TOKA
  13.14.1 T&K TOKA Company Information
  13.14.2 T&K TOKA Radiation Curable Formulation Product Portfolios and Specifications
  13.14.3 T&K TOKA Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 T&K TOKA Main Business Overview
  13.14.5 T&K TOKA Latest Developments
13.15 Heygey
  13.15.1 Heygey Company Information
  13.15.2 Heygey Radiation Curable Formulation Product Portfolios and Specifications
  13.15.3 Heygey Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Heygey Main Business Overview
  13.15.5 Heygey Latest Developments
13.16 Suzhou Mingda
  13.16.1 Suzhou Mingda Company Information
  13.16.2 Suzhou Mingda Radiation Curable Formulation Product Portfolios and Specifications
  13.16.3 Suzhou Mingda Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Suzhou Mingda Main Business Overview
  13.16.5 Suzhou Mingda Latest Developments
13.17 Himonia
  13.17.1 Himonia Company Information
  13.17.2 Himonia Radiation Curable Formulation Product Portfolios and Specifications
  13.17.3 Himonia Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Himonia Main Business Overview
  13.17.5 Himonia Latest Developments
13.18 Tianjin Jiuri New
  13.18.1 Tianjin Jiuri New Company Information
  13.18.2 Tianjin Jiuri New Radiation Curable Formulation Product Portfolios and Specifications
  13.18.3 Tianjin Jiuri New Radiation Curable Formulation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.18.4 Tianjin Jiuri New Main Business Overview
  13.18.5 Tianjin Jiuri New Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Radiation Curable Formulation Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Radiation Curable Formulation Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ultraviolet (UV) Curing
Table 4. Major Players of Electron beam (EB) Curing
Table 5. Global Radiation Curable Formulation Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Radiation Curable Formulation Sales Market Share by Type (2018-2023)
Table 7. Global Radiation Curable Formulation Revenue by Type (2018-2023) & ($ million)
Table 8. Global Radiation Curable Formulation Revenue Market Share by Type (2018-2023)
Table 9. Global Radiation Curable Formulation Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Radiation Curable Formulation Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Radiation Curable Formulation Sales Market Share by Application (2018-2023)
Table 12. Global Radiation Curable Formulation Revenue by Application (2018-2023)
Table 13. Global Radiation Curable Formulation Revenue Market Share by Application (2018-2023)
Table 14. Global Radiation Curable Formulation Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Radiation Curable Formulation Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Radiation Curable Formulation Sales Market Share by Company (2018-2023)
Table 17. Global Radiation Curable Formulation Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Radiation Curable Formulation Revenue Market Share by Company (2018-2023)
Table 19. Global Radiation Curable Formulation Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Radiation Curable Formulation Producing Area Distribution and Sales Area
Table 21. Players Radiation Curable Formulation Products Offered
Table 22. Radiation Curable Formulation Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Radiation Curable Formulation Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Radiation Curable Formulation Sales Market Share Geographic Region (2018-2023)
Table 27. Global Radiation Curable Formulation Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Radiation Curable Formulation Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Radiation Curable Formulation Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Radiation Curable Formulation Sales Market Share by Country/Region (2018-2023)
Table 31. Global Radiation Curable Formulation Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Radiation Curable Formulation Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Radiation Curable Formulation Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Radiation Curable Formulation Sales Market Share by Country (2018-2023)
Table 35. Americas Radiation Curable Formulation Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Radiation Curable Formulation Revenue Market Share by Country (2018-2023)
Table 37. Americas Radiation Curable Formulation Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Radiation Curable Formulation Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Radiation Curable Formulation Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Radiation Curable Formulation Sales Market Share by Region (2018-2023)
Table 41. APAC Radiation Curable Formulation Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Radiation Curable Formulation Revenue Market Share by Region (2018-2023)
Table 43. APAC Radiation Curable Formulation Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Radiation Curable Formulation Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Radiation Curable Formulation Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Radiation Curable Formulation Sales Market Share by Country (2018-2023)
Table 47. Europe Radiation Curable Formulation Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Radiation Curable Formulation Revenue Market Share by Country (2018-2023)
Table 49. Europe Radiation Curable Formulation Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Radiation Curable Formulation Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Radiation Curable Formulation Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Radiation Curable Formulation Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Radiation Curable Formulation Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Radiation Curable Formulation Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Radiation Curable Formulation Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Radiation Curable Formulation Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Radiation Curable Formulation
Table 58. Key Market Challenges & Risks of Radiation Curable Formulation
Table 59. Key Industry Trends of Radiation Curable Formulation
Table 60. Radiation Curable Formulation Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Radiation Curable Formulation Distributors List
Table 63. Radiation Curable Formulation Customer List
Table 64. Global Radiation Curable Formulation Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Radiation Curable Formulation Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Radiation Curable Formulation Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Radiation Curable Formulation Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Radiation Curable Formulation Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Radiation Curable Formulation Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Radiation Curable Formulation Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Radiation Curable Formulation Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Radiation Curable Formulation Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Radiation Curable Formulation Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Radiation Curable Formulation Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Radiation Curable Formulation Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Radiation Curable Formulation Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Radiation Curable Formulation Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. BASF SE Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 79. BASF SE Radiation Curable Formulation Product Portfolios and Specifications
Table 80. BASF SE Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. BASF SE Main Business
Table 82. BASF SE Latest Developments
Table 83. DIC Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 84. DIC Radiation Curable Formulation Product Portfolios and Specifications
Table 85. DIC Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. DIC Main Business
Table 87. DIC Latest Developments
Table 88. Arkema (Sartomer) Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 89. Arkema (Sartomer) Radiation Curable Formulation Product Portfolios and Specifications
Table 90. Arkema (Sartomer) Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Arkema (Sartomer) Main Business
Table 92. Arkema (Sartomer) Latest Developments
Table 93. Cytec (Solvay S.A.) Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 94. Cytec (Solvay S.A.) Radiation Curable Formulation Product Portfolios and Specifications
Table 95. Cytec (Solvay S.A.) Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Cytec (Solvay S.A.) Main Business
Table 97. Cytec (Solvay S.A.) Latest Developments
Table 98. DuPont Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 99. DuPont Radiation Curable Formulation Product Portfolios and Specifications
Table 100. DuPont Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. DuPont Main Business
Table 102. DuPont Latest Developments
Table 103. Royal DSM Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 104. Royal DSM Radiation Curable Formulation Product Portfolios and Specifications
Table 105. Royal DSM Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Royal DSM Main Business
Table 107. Royal DSM Latest Developments
Table 108. IGM Resins Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 109. IGM Resins Radiation Curable Formulation Product Portfolios and Specifications
Table 110. IGM Resins Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. IGM Resins Main Business
Table 112. IGM Resins Latest Developments
Table 113. Allnex Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 114. Allnex Radiation Curable Formulation Product Portfolios and Specifications
Table 115. Allnex Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Allnex Main Business
Table 117. Allnex Latest Developments
Table 118. Chongqing Changfeng Chemical Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 119. Chongqing Changfeng Chemical Radiation Curable Formulation Product Portfolios and Specifications
Table 120. Chongqing Changfeng Chemical Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Chongqing Changfeng Chemical Main Business
Table 122. Chongqing Changfeng Chemical Latest Developments
Table 123. Eternal Materials Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 124. Eternal Materials Radiation Curable Formulation Product Portfolios and Specifications
Table 125. Eternal Materials Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Eternal Materials Main Business
Table 127. Eternal Materials Latest Developments
Table 128. Miwon Specialty Chemical Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 129. Miwon Specialty Chemical Radiation Curable Formulation Product Portfolios and Specifications
Table 130. Miwon Specialty Chemical Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Miwon Specialty Chemical Main Business
Table 132. Miwon Specialty Chemical Latest Developments
Table 133. Jiangsu Sanmu Group Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 134. Jiangsu Sanmu Group Radiation Curable Formulation Product Portfolios and Specifications
Table 135. Jiangsu Sanmu Group Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Jiangsu Sanmu Group Main Business
Table 137. Jiangsu Sanmu Group Latest Developments
Table 138. PPG Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 139. PPG Radiation Curable Formulation Product Portfolios and Specifications
Table 140. PPG Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. PPG Main Business
Table 142. PPG Latest Developments
Table 143. T&K TOKA Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 144. T&K TOKA Radiation Curable Formulation Product Portfolios and Specifications
Table 145. T&K TOKA Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. T&K TOKA Main Business
Table 147. T&K TOKA Latest Developments
Table 148. Heygey Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 149. Heygey Radiation Curable Formulation Product Portfolios and Specifications
Table 150. Heygey Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. Heygey Main Business
Table 152. Heygey Latest Developments
Table 153. Suzhou Mingda Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 154. Suzhou Mingda Radiation Curable Formulation Product Portfolios and Specifications
Table 155. Suzhou Mingda Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Suzhou Mingda Main Business
Table 157. Suzhou Mingda Latest Developments
Table 158. Himonia Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 159. Himonia Radiation Curable Formulation Product Portfolios and Specifications
Table 160. Himonia Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 161. Himonia Main Business
Table 162. Himonia Latest Developments
Table 163. Tianjin Jiuri New Basic Information, Radiation Curable Formulation Manufacturing Base, Sales Area and Its Competitors
Table 164. Tianjin Jiuri New Radiation Curable Formulation Product Portfolios and Specifications
Table 165. Tianjin Jiuri New Radiation Curable Formulation Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 166. Tianjin Jiuri New Main Business
Table 167. Tianjin Jiuri New Latest Developments

LIST OF FIGURES

Figure 1. Picture of Radiation Curable Formulation
Figure 2. Radiation Curable Formulation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiation Curable Formulation Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Radiation Curable Formulation Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Radiation Curable Formulation Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ultraviolet (UV) Curing
Figure 10. Product Picture of Electron beam (EB) Curing
Figure 11. Global Radiation Curable Formulation Sales Market Share by Type in 2022
Figure 12. Global Radiation Curable Formulation Revenue Market Share by Type (2018-2023)
Figure 13. Radiation Curable Formulation Consumed in Coatings
Figure 14. Global Radiation Curable Formulation Market: Coatings (2018-2023) & (Kiloton)
Figure 15. Radiation Curable Formulation Consumed in Inks
Figure 16. Global Radiation Curable Formulation Market: Inks (2018-2023) & (Kiloton)
Figure 17. Radiation Curable Formulation Consumed in Adhesives
Figure 18. Global Radiation Curable Formulation Market: Adhesives (2018-2023) & (Kiloton)
Figure 19. Radiation Curable Formulation Consumed in Electronics
Figure 20. Global Radiation Curable Formulation Market: Electronics (2018-2023) & (Kiloton)
Figure 21. Global Radiation Curable Formulation Sales Market Share by Application (2022)
Figure 22. Global Radiation Curable Formulation Revenue Market Share by Application in 2022
Figure 23. Radiation Curable Formulation Sales Market by Company in 2022 (Kiloton)
Figure 24. Global Radiation Curable Formulation Sales Market Share by Company in 2022
Figure 25. Radiation Curable Formulation Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Radiation Curable Formulation Revenue Market Share by Company in 2022
Figure 27. Global Radiation Curable Formulation Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Radiation Curable Formulation Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Radiation Curable Formulation Sales 2018-2023 (Kiloton)
Figure 30. Americas Radiation Curable Formulation Revenue 2018-2023 ($ Millions)
Figure 31. APAC Radiation Curable Formulation Sales 2018-2023 (Kiloton)
Figure 32. APAC Radiation Curable Formulation Revenue 2018-2023 ($ Millions)
Figure 33. Europe Radiation Curable Formulation Sales 2018-2023 (Kiloton)
Figure 34. Europe Radiation Curable Formulation Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Radiation Curable Formulation Sales 2018-2023 (Kiloton)
Figure 36. Middle East & Africa Radiation Curable Formulation Revenue 2018-2023 ($ Millions)
Figure 37. Americas Radiation Curable Formulation Sales Market Share by Country in 2022
Figure 38. Americas Radiation Curable Formulation Revenue Market Share by Country in 2022
Figure 39. Americas Radiation Curable Formulation Sales Market Share by Type (2018-2023)
Figure 40. Americas Radiation Curable Formulation Sales Market Share by Application (2018-2023)
Figure 41. United States Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Radiation Curable Formulation Sales Market Share by Region in 2022
Figure 46. APAC Radiation Curable Formulation Revenue Market Share by Regions in 2022
Figure 47. APAC Radiation Curable Formulation Sales Market Share by Type (2018-2023)
Figure 48. APAC Radiation Curable Formulation Sales Market Share by Application (2018-2023)
Figure 49. China Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Radiation Curable Formulation Sales Market Share by Country in 2022
Figure 57. Europe Radiation Curable Formulation Revenue Market Share by Country in 2022
Figure 58. Europe Radiation Curable Formulation Sales Market Share by Type (2018-2023)
Figure 59. Europe Radiation Curable Formulation Sales Market Share by Application (2018-2023)
Figure 60. Germany Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Radiation Curable Formulation Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Radiation Curable Formulation Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Radiation Curable Formulation Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Radiation Curable Formulation Sales Market Share by Application (2018-2023)
Figure 69. Egypt Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Radiation Curable Formulation Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Radiation Curable Formulation in 2022
Figure 75. Manufacturing Process Analysis of Radiation Curable Formulation
Figure 76. Industry Chain Structure of Radiation Curable Formulation
Figure 77. Channels of Distribution
Figure 78. Global Radiation Curable Formulation Sales Market Forecast by Region (2024-2029)
Figure 79. Global Radiation Curable Formulation Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Radiation Curable Formulation Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Radiation Curable Formulation Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Radiation Curable Formulation Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Radiation Curable Formulation Revenue Market Share Forecast by Application (2024-2029)


More Publications